ArticleOPEN ACCESS

Identification of Novel MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating the EGFR-ADAM17 Axis: An in Silico Analysis

ACS Pharmacology and Translational Science
DOI: 10.1021/acsptsci.0c00199
7Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cancer patients contracting SARS-CoV-2 encounter additional challenges due to inflammatory bursts and lymphopenia, which may aggravate breast cancer prognosis. In this in silico analysis, we identified the potential of miRNAs as new therapeutic targets to treat breast cancer patients infected with COVID-19 via the regulation of ADAM17 and EGFR expression microRNAs.

Author supplied keywords

Cite

CITATION STYLE

APA

Mukhopadhyay, D., Alsawaftah, N., & Husseini, G. A. (2021, February 12). Identification of Novel MicroRNAs as Promising Therapeutics for SARS-CoV-2 by Regulating the EGFR-ADAM17 Axis: An in Silico Analysis. ACS Pharmacology and Translational Science. American Chemical Society. https://doi.org/10.1021/acsptsci.0c00199

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free